Kappa Free Light Chains Intrathecal Synthesis Biomarkers are Efficient Tools for the Diagnosis of Multiple Sclerosis: a Large Multicenter Cohort Study (S19.003)
2022; Lippincott Williams & Wilkins; Volume: 98; Issue: 18_supplement Linguagem: Inglês
10.1212/wnl.98.18_supplement.1600
ISSN1526-632X
AutoresMichaël Levraut, Xavier Ayrignac, Kévin Bigaut, Sabine Chabalier, Manon Rival, Hanane Agherbi, Sanae Squalli, Hélène Zéphir, Tifanie Alberto, Jean David Pekar, Jonathan Ciron, Noellie Freitas, Damien Biotti, Jean-Phillippe Camdessanche, Yannick Tholance, Vincent Visneux, Olivier Casez, Bertrand Toussaint, Jeanne Marion, Audrey Le Gouëllec, Thibault Moreau, Daniela Lakomy, Audrey Thomasset, Élisabeth Maillart, Delphine Sterlin, Aude Maurousset, Auriane Rocher, Mikaël Cohen, Adrien Delourme, Saskia Bresch, David Laplaud, Edith Bigot–Corbel, Jean Pelletier, José Boucraut, Pierre Labauge, Sophie Huby, Thierry Vincent, de Sèze, Isabelle Jahn, Barbara Seitz‐Polski, Éric Thouvenot, Christine Lebrun‐Frénay,
Tópico(s)Mycobacterium research and diagnosis
ResumoDetermination of kappa free light chains (KFLC) index (KFLCi) and intrathecal fraction (KFLC IF) cut-off values for multiple sclerosis (MS)-related immunoglobulin intrathecal synthesis diagnosis and rule-out non-MS inflammatory disorders.
Referência(s)